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A B S T R A C T
Electrospun nanoﬁbers have the potential to achieve high drug loading and the ability to sustain drug release.
Mechanical properties of the drug-incorporated ﬁbers suggest the importance of drug–polymer interactions. In
this study, we investigated the mechanical properties of electrospun polycaprolactone (PCL) and poly (D,L-
lactic-co-glycolic) acid (PLGA) ﬁbers at various blend ratios in the presence and absence of a small molecule
hydrophilic drug, tenofovir (TFV). Young׳s modulus of the blend ﬁbers showed dependence on PLGA content
and the addition of the drug. At a PCL/PLGA (20/80) composition, Young׳s modulus and tensile strength were
independent of drug loading up to 40 wt% due to oﬀsetting eﬀects from drug–polymer interactions. In vitro
drug release studies suggested that release of TFV signiﬁcantly decreased ﬁber mechanical properties. In
addition, mechanically stretched ﬁbers displayed a faster release rate as compared to the non-stretched ﬁbers.
Finally, drug partition in the blend ﬁbers was estimated using a mechanical model and then experimentally
conﬁrmed with a composite of individually stacked ﬁber meshes. This work provides scientiﬁc understanding on
the dependence of drug release and drug loading on the mechanical properties of drug-eluting ﬁbers.
1. Introduction
Electrospinning is a process that utilizes an electric ﬁeld to
continuously draw ﬁbers from a viscous polymeric solution through
rapid solvent evaporation. One of the advantages in electrospinning is
that virtually any polymer can be electrospun into ﬁbers (Huang et al.,
2003). The resulting nonwoven ﬁbrous structure along with the
versatility of polymer selections and polymer blend combinations
makes electrospun ﬁbers an ideal platform for many biomedical
applications (Jiang et al., 2015). For example, ﬁbers electrospun from
polymer blends of polycaprolactone and polyglyconate were used in
tissue engineering as biomaterials to support cell growth where ﬁber
degradation and mechanical properties were dependent on polymer
compositions (Schindler et al., 2013). Another promising biomedical
application for electrospun ﬁbers of polymer blends is the ability to
modulate drug release (Chou et al., 2015). For example, release rate of
teriﬂunomide (up to 15 wt%) from blend ﬁbers of poly(lactic acid) and
poly(butylene adipate) was modulated by blend polymer compositions
(Siafaka et al., 2016). Furthermore, poly(lactide-co-glycolide), poly(-
ethylene glycol)-b-poly(lactide), and poly(lactide) (80/5/15) blend
ﬁbers showed sustained release of cefoxitin sodium for 7 days as
compared to burst release from poly(lactide-co-glycolide) ﬁbers in 6 h
(Kim et al., 2004). More importantly, the sustained release behavior of
cefoxitin sodium suggested drug entrapment within the hydrophilic
block of poly(ethylene glycol)-b-poly(lactide) forming drug/poly(ethy-
lene glycol)-b-poly(lactide) complex, which was further encapsulated in
the polymer ﬁbers after electrospinning. These examples demonstrate
that ﬁbers comprised of polymer blends have a great potential for
tuning drug miscibility and the resulting drug–polymer interactions
could lead to diﬀerent release proﬁles. While many studies report on
drug release from blend ﬁbers, the eﬀect of speciﬁc drug–polymer
interactions that contribute to the observed release proﬁle has not been
investigated. This is perhaps due to the diﬃculty of measuring drug
partitioning in a blended polymer system. In this work, we used
mechanical testing as a probe for drug–polymer interactions that could
inform drug partitioning in blend ﬁbers of polyesters loaded with a
hydrophilic small molecule drug.
The design and function of pharmaceutical electrospun materials
may be limited by their relatively low stiﬀness and strength due to the
porous structure. Several factors appear to aﬀect the mechanical
properties of electrospun ﬁbers, such as ﬁber diameters and defects
along the ﬁber axial direction (Chen et al., 2009b; Huang et al., 2004).
In addition, ﬁber alignment has been reported to signiﬁcantly aﬀect
their mechanical properties (Chen et al., 2009a; Kancheva et al., 2014;
Lee and Deng, 2012; Nerurkar et al., 2007; Stoyanova et al., 2014). The
alignment of ﬁbers provides an alternative strategy in the design of
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pharmaceutical electrospun materials by tuning the mechanical prop-
erties independent of their drug release behaviors. More importantly,
mechanical properties may be used to proxy eﬀects of electrospun
materials on drug loading, drug–polymer interaction, release behavior,
drug partitioning, and polymer degradation. This was demonstrated by
incorporation of small molecule drugs and other excipients in ﬁbers
that resulted in lowering the crystallinity of semi-crystalline polyester
and polyether materials (Yakub et al., 2014). Others have shown that
increasing PLGA composition in PCL/PLGA blends decreased the
average PCL crystallinity, suggesting the two polymers were miscible
and PLGA chains may be disrupting PCL crystalline domains (You
et al., 2006). These changes in crystallinity due to drug loading or blend
polymers are an indication of drug–polymer interactions and can be
directly measured through the mechanical properties of the ﬁbers. For
example, tensile strength of poly(lactic-co-glycolic acid) ﬁbers signiﬁ-
cantly decreased from 5% to 10% when increasing bupivacaine HCl
loading from 5% to 22% (Weldon et al., 2012). Furthermore, mechan-
ical properties of the poly(lactic-co-glycolic acid) ﬁbers decreased due
to in vitro polymer degradation, which further increased the release
rate of bupivacaine HCl. Therefore, we utilize mechanical testing to
infer the eﬀects of drug loading and drug release rates from blend ﬁbers
of PCL/PLGA at various compositions.
Here, we study the mechanical performance associated with loading
of tenofovir (TFV), a hydrophilic small molecule drug, into ﬁbers of
polycaprolactone (PCL) and poly (D,L-lactic-co-glycolic) acid (PLGA).
We hypothesized that hydrophilic nature of TFV facilitates the loss of
mechanical properties during in vitro drug release. PCL/PLGA polymer
blends appear to be an ideal system for investigating drug–polymer
interactions since our previous study suggested a high compatibility of
TFV with solid dispersions of semi-crystalline PCL, amorphous PLGA,
and their blends (Carson et al., 2016). Here, we show that increasing
drug loading increases drug release rates, and consequently results in a
signiﬁcant loss of mechanical properties. In addition, in vitro release
studies from mechanically stretched ﬁbers reveal a much faster release
rate than the non-stretched ﬁbers. Drug partitioning in PCL/PLGA
blend ﬁbers is further conﬁrmed by experimentally stretching a stacked
ﬁber composition. Our studies contribute signiﬁcantly to the knowl-
edge of electrospun drug-eluting ﬁbers by correlating the mechanical
performance related to drug release and provide important under-
standing to evaluating these correlations for medical ﬁbers.
2. Materials and methods
2.1. Materials
Polycaprolactone (PCL) with an average molecular weight (Mw) of
80,000 Da was purchased from Sigma-Aldrich (St. Louis, MO, USA).
Poly (D,L-lactic-co-glycolic) acid (PLGA) with a lactic acid to glycolic
acid ratio of 50:50, an acid end cap, and an average molecular weight
(Mw) of 100,000 Da was purchased from PolySciTech
® (West
Lafayette, IN, USA). Tenofovir (TFV) was provided by CONRAD
(Arlington, VA, USA). Dimethyl sulfoxide (DMSO) and hexaﬂuoroiso-
propanol (HFIP) were purchased from VWR® (Radnor, PA, USA) and
Oakwood Laboratories (Wayne County, MI, USA). Phosphate-buﬀered
saline (PBS) was purchased from Mediatech Inc. (Manassas, VA, USA).
HPLC grade acetonitrile, triﬂuoroacetic acid, and HPLC grade water
were purchased from Fisher Scientiﬁc (Pittsburgh, PA, USA). All
materials were used as received without any further modiﬁcation.
2.2. Preparation of electrospun PCL/PLGA ﬁbers
To prepare polymer solutions for electrospinning, PCL and PLGA
were dissolved in HFIP at 15% (w/v). PCL/PLGA blends, by adjusting
the weight ratio of PCL to PLGA at 100:0, 80:20, 60:40, 40:60, 20:80,
and 0:100, were dissolved in HFIP at 15% (w/v). All polymer solutions
in their glass vials were placed on a ThermoScientiﬁc LabquakeTM tube
rotator (Waltham, MA, USA) for overnight mixing to ensure complete
dissolution of the polymer. TFV was added to polymer solutions at 10–
40% (w/w)=wt% prior to electrospinning. All solutions were extruded
from a 1 mL glass syringe, through a 21 G blunt-end needle at 20 μL/
min, using a NE-1000 programmable single syringe pump
(Farmingdale, NY, USA). During electrospinning, the applied voltage
was 10 kV and the distance from the tip of the needle to the collector
was maintained at 15 cm. Fibers were collected on a grounded
stationary collector and/or a rotational drum covered with a wax
paper. The rotational speed was 3000 rpm, and the corresponding
linear rotational speed was 200 cm s−1 at the surface of the collector.
Resulting ﬁber mats were dried and stored in a vacuum desiccator until
used for analysis.
2.3. Mechanical testing
Mechanical tests were conducted on a single column screw-driven
Instron® 5943 universal materials testing machine (Norwood, MA,
USA) under 24 ± 1 °C and 45 ± 5% RH in accordance with ASTM
standard D5034-95. Dog-bone tensile specimens (ASTM standard
D1708-96, 22 mm in nominal length and 5 mm in width) were care-
fully prepared by punching the electrospun ﬁber mats from a stainless
steel die (ODC Tooling and Molds, Waterloo ON, Canada). Specimens
with any visible defects were discarded, and a total of 5 specimens were
used for each test group. Tensile tests were performed at a strain rate of
0.01 s−1 using Instron pneumatic clamps where load and displacement
data were obtained. Young׳s modulus (linear region before 2% strain)
and tensile strength (zero slope) were calculated from each correspond-
ing stress–strain curve where the thickness of each sample was
measured by a thickness gauge (MAPRA technik, Loughton, Essex,
UK). Average thickness of the test specimens ranged from 0.05 mm to
0.15 mm. Data were analyzed using 2-way ANOVA (Prism, GraphPad).
2.4. Mechanical model
A mechanical model based on the results from average Young׳s
moduli was used to validate drug partition in PCL/PLGA ﬁbers.
Average Young׳s moduli of blank PCL/PLGA ﬁbers were ﬁtted into
rule of mixtures assuming the blend ﬁber system behaved similarly as a
composite material. A Voigt model was used to simplify the interpreta-
tion of the results:
E E x E x=[ ×( )]+[ ×(1 − )]PCL PLGA PCL PLGA/ , where x is the percentage con-
centration of PCL in blend ﬁbers. Assuming drug–polymer interactions
(e.g., TFV-PCL and TFV-PLGA) attributed to individual increases or
decreases in Young׳s moduli of the blend ﬁbers, the model was then
modiﬁed as:
E E E η E η= +(∆ × )+(∆ × ),overall PCL PLGA PCL PCL TFV PLGA PLGA TFV/ / /
where ηPCL TFV/ is the percentage of overall TFV partitioned in PCL and
ηPLGA TFV/ is the percentage of overall TFV partitioned in PLGA.
2.5. In vitro drug release studies
1/4 in. diameter discs were taken from ﬁber mats using a metal die.
Sample thickness was measured using a thickness gauge and initial
sample mass was measured using a Mettler-Toledo XS105 analytical
balance (Columbus, OH, USA). Fibers were placed into glass vials
containing 10 mL of pre-warmed (37 °C) PBS release media (pH~7.2–
7.4). Samples were kept at 37 °C in a rotary incubator at 200 rpm. At
predetermined time points out to 240 h, 200 μL of liquid samples were
placed into HPLC vials and replaced with fresh media to maintain sink
conditions. HPLC samples were stored at 4 °C prior to analysis. The
extent of drug release was expressed as percentage cumulative release
and calculated as the concentration of drug in the release media
relative to the initial drug concentration in the ﬁbers.
HPLC analysis was used to quantify tenofovir concentration in the
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release media. A Shimadzu Prominence LC20AD UV-HPLC system
equipped with a Phenomenex Kinetex C18 column (5 µm,
250×4.6 mm) and LCSolutions software were used to quantify drug
levels in samples. The HPLC mobile phase consisted of a 72% HPLC
graded H2O with 0.045% triﬂuoroacetic acid buﬀer and 28% acetoni-
trile with 0.036% triﬂuoroacetic acid buﬀer. Tenovoﬁr was freely
soluble in the mobile phase. The HPLC methods included 30 °C column
temperature, 1 mL/min ﬂow rate, 10 min run time, 20 μL sample
injection volume and UV/vis detection at 259 nm. Tenofovir standard
curves were prepared by dissolving 25 mg of tenofovir in PBS to a
concentration of 200 μg/mL and diluting serially at 1:2 until concen-
trations of 0.1 ug/mL. Later, the tenofovir standards and unknown
samples were detected by UV-HPLC as described previously (Carson
et al., 2016). Drug loading (encapsulation eﬃciency) was quantiﬁed by
comparing drug-containing ﬁbers dissolved in DMSO to a tenofovir
standard curve in DMSO (0.1–500 μg/mL). Results were the average of
three independent measurements.
2.6. Materials characterization
Surface morphologies of electrospun nanoﬁbers were investigated
using a scanning electron microscopy (SEM). Circular punches were
taken from the ﬁber mats and sputter coated with Au/Pd for 90 s using
a SPI sputter-coater (West Chester, PA, USA) at 80–100 mTorr. SEM
micrographs were acquired from a FEI Sirion SEM system (UW,
NanoTech User Facility) at 5 kV, using a spot size 3, and a working
distance of 5.0 cm. Post-stretched ﬁber images were taken at near or
less than 1 mm from the fracture site (n=100). Image analysis was
carried out by image processing software (ImageJ, National Institutes
of Health, Bethesda, MD, USA) using OrientationJ plugin for ﬁber
alignment measurement by applying a Riesz ﬁlter at 70% minimal
coherency and 2% minimal energy.
To measure sample shrinkage and mass loss after removing them
from release media, dogbone samples were allowed to air dry in
laboratory atmosphere. Square portions (clamping area) of the dog-
bone samples were used for sample shrinkage measurement with the
assumption that shrinkage of the sample was proportional within the
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Fig. 1. (a) Schematics of a dogbone specimen and its dimension used in this work. (b) Typical stress strain curves of electrospun randomly oriented PCL (dashed line) and PLGA (solid
line) ﬁbers, where PLGA ﬁbers exhibit a necking behavior (arrow pointing). (c) SEM images of PLGA ﬁber alignment due to mechanical stretching at 0%, 2%, 50%, and 280% strain. An
arrow indicates load-applying direction. Scale bar=20 μm. (d) Distribution plots of ﬁber alignment from the acquired SEM images. Load-induced ﬁber alignment was analyzed by
ImageJ software with OrientationJ plugin. Results suggested increasing strain increased ﬁber alignment. Gray area represents standard deviation (n=5).
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samples. Mass of the sample was weighted daily and mass values were
accepted with less than 1% change after 24 h. Percentage shrinkage
and mass loss were calculated based on the following equation:
Shrinkage A A
A
(%)= − ×100D i
i
Mass loss W W
W
(%)= − ×100,D i
i
where AD is the dried square clamping area of the dogbone samples, Ai
is the initial area, WD is the dried weight, and Wi is the initial weight.
For mechanical testing on dogbone specimens after removing from the
release media, new nominal length and width after shrinkage was used
for mechanical property analysis. Each sample was set for its corre-
sponding nominal length for accurate strain comparison.
2.7. Statistical analyses
Unless speciﬁed, data were described as mean ± standard deviation.
One-way analyses of variance (ANOVA) were performed for compara-
tive studies at an acceptable signiﬁcance level of P < 0.05.
3. Results
3.1. Stress–strain curves of PCL/PLGA ﬁbers
Fundamental studies on mechanical properties of electrospun
nanoﬁbers typically focus on uniaxial tensile testing of randomly
orientated or aligned ﬁber conﬁgurations. In this study, blends of
PCL/PLGA nanoﬁbers were electrospun at various PCL to PLGA ratios
followed by mechanical stretching of the as-punched dogbone speci-
mens under a uniaxial load in tension (Fig. 1a). Representative stress–
strain curves of randomly orientated PCL and PLGA electrospun
nanoﬁbers highlight features that are intrinsic to the mechanical
behaviors of these polyesters (Fig. 1b). Using PLGA nanoﬁbers as an
example, the stress–strain curve can be divided into an elastic, yielding
and strain-hardening region. Speciﬁcally, the initial linear elastic
region occurs up to 2% strain where stretching of the ﬁber mats results
in slight alignment of the ﬁber network to the applied load direction
(Fig. 1c). Increasing applied strain to 50% and 280% signiﬁcantly
increased ﬁber alignment to 30° and 14° in full width at half-
maximum, respectively (Fig. 1d). Additionally, a noticeable necking
phenomenon is observed from PLGA samples indicating the onset of
plastic deformation in mechanical behavior. In general, PLGA samples
are stiﬀer and stronger than PCL samples. By contrast, PCL appears to
be more ductile than PLGA.
3.2. Mechanical properties of PCL/PLGA/TFV ﬁbers
We measured the Young׳s modulus and tensile strength of PCL/
PLGA blend ﬁbers alone and after incorporating TFV to understand the
eﬀect of drug loading on ﬁber mechanical properties. Yield strength,
elongation to failure, and toughness (work to failure) of PCL/PLGA/
TFV ﬁbers are reported in Supplementary Information. The average
Young׳s moduli of PCL and PLGA nanoﬁbers were 24 ± 4 MPa and 244
± 22 MPa, respectively (Fig. 2a). For the blended polymer ﬁbers,
increasing PLGA composition from 0% to 100% signiﬁcantly increased
the average Young׳s modulus by approximately ﬁve-fold due to the high
inherent stiﬀness of PLGA (P < 0.05). By contrast, we did not observe
the same magnitude increase in the average Young׳s moduli as a
function of PLGA content once the polymer blend ﬁbers were loaded
with 15 wt% of TFV. Our results suggests that the stiﬀening mechanism
due to increasing PLGA content in PCL/PLGA ﬁbers was oﬀset by the
incorporation of TFV at a level of 15 wt%, which alone signiﬁcantly
reduced the ductility of the ﬁbers (see Supplementary Figure S1).
Fig. 2. Mechanical properties of blank PCL/PLGA ﬁbers (black dots) and ﬁbers loaded with 15 wt% of TFV (gray dots): (a) Young׳s modulus and (b) tensile strength. Mechanical
properties of 20PCL/80PLGA ﬁbers loaded with TFV up to 40 wt%: (c) Young׳s modulus and (d) tensile strength.
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Unlike Young׳s modulus, average tensile strength of PCL/PLGA ﬁbers
at various PLGA compositions showed minimal eﬀects on ﬁber
composition or incorporation of TFV at 15 wt% (Fig. 2b). Overall,
average tensile strength of PCL/PLGA/TFV ﬁbers ranged from 3.1 ±
0.9 MPa to 6.4 ± 0.9 MPa.
We demonstrated previously that PCL/PLGA (20/80) ﬁbers provide
zero-order drug release when loaded with 15 wt% TFV (Carson et al.,
2016), and selected this composition to measure the eﬀect of various
TFV drug loading on mechanical properties of the bulk mesh. Within
this polyester composition, we observed that the average Young׳s
modulus (Fig. 2c) and tensile strength (Fig. 2d) remained constant at
all TFV loadings from 0 wt% to 40 wt%. Although the Young׳s modulus
and average tensile strength appeared to decrease slightly with
increasing TFV loading, the correlation was insigniﬁcant. Overall, our
results showed that the modulus and tensile strength of PCL/PLGA
(20/80) ﬁbers were independent of TFV loading up to 40 wt%.
3.3. Eﬀect of aligned and random PCL/PLGA ﬁbers
Structure-property relationships of random and aligned ﬁbers have
been reported previously (Katta et al., 2004; Li et al., 2007;
Stylianopoulos et al., 2008). Here, we measured Young׳s modulus
and tensile strength of aligned PCL and PLGA ﬁbers and compared
their values to the same properties obtained from various PCL/PLGA
blend ﬁbers. In addition, separate sets of PCL and PLGA ﬁbers were
collected on a rotation drum and mechanically tested in parallel and in
perpendicular to the ﬁber alignment direction (drum rotating direc-
tion) (Figs. 3a and b). The degree of ﬁber alignment appeared to
depend on productivity of the ﬁbers during electrospinning, with
higher productivity inversely correlated with higher alignment
(Fig. 3c and d). Both PCL and PLGA ﬁbers showed the highest tensile
strength when ﬁber orientation was pre-aligned parallel to the applied
load direction (Fig. 3c). By contrast, the lowest tensile strength was
obtained from ﬁbers orientated perpendicular to the applied load
direction. Furthermore, the tensile strength of randomly oriented
ﬁbers fell in between the values of pre-aligned ﬁbers. As noted
previously, we observed that varying PCL and PLGA composition in
the blend ﬁbers signiﬁcantly aﬀected ﬁber stiﬀness whereas tensile
strength remained unchanged. In addition to the composition eﬀect,
ﬁber alignment also had a signiﬁcant impact on the stiﬀness of the
samples. Trend lines between PCL and PLGA ﬁbers showed the lower
and upper boundaries of tensile strength and Young׳s modulus for this
particular blend ﬁber system. Therefore, within these boundary limits,
ﬁbers of particular strength and stiﬀness can be tailored based on the
degree of alignment and the composition of PCL and PLGA.
3.4. Fiber structure and morphology
Changes in PCL/PLGA/TFV ﬁber morphology were investigated
using SEM images after mechanical testing to investigate drug polymer
compatibility (Fig. 4). Blend ﬁbers without TFV exhibited a smooth and
defect-free surface with no morphological changes after mechanical
testing (data not shown). Conversely, after mechanical stretching, we
observed that PCL ﬁbers (100% and 80% content) loaded with 15 wt%
of TFV displayed surface aggregates (D=135 ± 35 nm). The amount of
surface inhomogeneities appeared to decrease with increasing PLGA
content in the ﬁbers. This observation may suggest that TFV is more
compatible with PLGA than PCL due to the excess of carbonyl groups in
PLGA that can serve as hydrogen bonding sites for TFV. Fiber
diameters were 2.0 ± 0.3 μm and 1.1 ± 0.1 μm for PCL and PLGA ﬁbers
respectively whereas ﬁber diameter decreased to 0.7 ± 0.2 μm after
mechanical stretching. It seems that micro-defects (e.g., cracks) formed
around this ﬁber diameter, which would limit the ability to further
reduce ﬁber diameter by continued stretching. In addition, elongation
of PLGA ﬁbers is expected to be less than that of PCL ﬁbers (see
Supplementary Figure S1) since PLGA originally has a smaller ﬁber
diameter than PCL ﬁbers. The reduction of the ﬁber diameter is related
to the total allowable amount of the strain that can be applied to the
ﬁbers.
3.5. Mechanical properties after in-vitro release
We have previously shown that PCL/PLGA (20/80) ﬁber formula-
tions sustain TFV release over 10 days in vitro (70% cumulative
release), and we show here minimal changes in mechanical properties
of this composition even with high TFV loading. We observed that
increasing TFV concentrations from 15 wt% to 40 wt% in the ﬁbers
increased the burst release magnitude of TFV from 20% to 85%,
respectively (Fig. 5a). These values are higher than our previous
reported data perhaps due to diﬀerences in sample shape and thickness
(Carson et al., 2016). We also investigated the eﬀect of drug release on
mechanical properties by measuring Young׳s modulus and tensile
strength at early time points prior to any signiﬁcant polymer degrada-
tion (t1/2=30 days for PLGA and t1/2 > 18 months for PCL) (Lu et al.,
1999; Park, 1995; Peña et al., 2006). Uniaxial tensile tests were
performed after 1, 48, and 240 h in the release media for both blank
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Fig. 3. SEM image of aligned ﬁbers (a) PCL and (b) PLGA collected from a rotation drum. An arrow indicates the drum rotating direction. Scale bar=100 μm. Distribution plots of (c)
PCL and (d) PLGA ﬁber alignment from the acquired SEM images. (e) Correlation of tensile stress – Young׳s modulus for aligned blank PCL/PLGA ﬁbers showing eﬀects of polymer
composition and ﬁber alignment (collected from a rotation drum) on their mechanical properties. Within the upper and lower boundaries, ﬁber mechanical properties are tunable
through ﬁber composition and ﬁber alignment.
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and TFV-released PCL/PLGA (20/80) samples. We observed that the
average Young׳s modulus and average tensile strength of the blank
PCL/PLGA (20/80) ﬁbers decreased signiﬁcantly in PBS over time
(Fig. 5b and c). Average Young׳s moduli decreased by 20% after 1 h
followed by an additional 30% after 48 h and 90% after 240 h in the
release media (P < 0.05). In addition, average tensile strength of the
same ﬁbers remained at a similar value after 1 h followed by a
signiﬁcant decrease of 40% after 48 h and an additional 40% after
240 h (P < 0.05). For drug-loaded ﬁbers, we observed signiﬁcant
decreases after 1 h in the average Young׳s moduli of 60%, 90%, and
90% for 15, 30, and 40 wt% TFV loading, respectively (P < 0.05). In
addition, average tensile strength of the same ﬁbers showed signiﬁcant
decreases of 60%, 50%, and 50% after 1 h (P < 0.05). At the end of the
study (e.g., 240 h), the average Young׳s modulus and tensile strength of
the drug-incorporated ﬁbers reduced 90% and 80%, respectively. In
general, we show that a signiﬁcant decrease in mechanical properties is
associated with drug release from electrospun ﬁbers.
3.6. Fiber structure after in-vitro release
Given that changes in physical characteristics aﬀect mechanical
performance of the drug-eluting ﬁbers, we measured sample shrinkage,
mass loss, and ﬁber structure to correlate with loss of mechanical
properties during drug release. We observed that shrinkages of PCL/
PLGA (20/80) ﬁber samples after 240 h were 37 ± 4%, 56 ± 1%, and 62
± 3% when loaded with 15, 30, and 40 wt% of TFV, respectively
(Fig. 6a). In addition, ﬁbers in the release media after 240 h experi-
enced mass losses of 13 ± 1%, 30 ± 1%, and 43 ± 1% when loaded with
TFV at 15, 30, and 40 wt%, respectively. According to the in vitro
release data (Fig. 5a), ﬁbers loaded with 15, 30, and 40 wt% achieved a
TFV cumulative release of 80 ± 5%, 97 ± 5%, and 96 ± 6% at 240 h,
respectively. Our data on the mass loss support the in vitro release
results, suggesting that the release of TFV attributes to the majority of
mass loss in the drug-eluting ﬁbers. Furthermore, ﬁber morphology
examined by SEM showed surface characteristic changes including
nodules, pores, and hollow sites (Fig. 6b). Of particular importance,
these surface defects result in stress concentration during mechanical
stretching and consequently becoming potential weak spots for failure
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Fig. 4. SEM images of PCL/PLGA ﬁbers loaded with 15 wt% of TFV before and after tensile testing (L=PCL; GA=PLGA). Scale bar=2 μm. Aggregates on the surface of 100PCL and
80L20GA ﬁbers after mechanical stretching to failure are noticeable. The amount of the surface aggregates decreases as increasing PLGA composition in the ﬁber. Fiber diameter
decreased as a result of mechanical stretching (n=100).
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Fig. 5. Decoupling losses of mechanical properties due to eﬀects of TFV release and polymer degradation. (a) TFV cumulative release curves for 20PCL/80PLGA ﬁbers loaded with 15,
30, and 40 wt% of TFV. Release proﬁles switched from a sustained release (15 wt% TFV) to a burst release at higher drug loading (30 and 40 wt% TFV). (b) Average Young׳s modulus of
20PCL/80PLGA ﬁbers with and without TFV loading after in the release media for 1, 48, and 240 h. The loss of Young׳s modulus at early time point is associated with release of TFV. At
prolonged time point, drug-load ﬁbers exhibit a similar Young׳s modulus as the blank ﬁbers. (c) Average tensile strength of 20PCL/80PLGA ﬁbers with and without TFV loading after in
the release media for 1, 48, and 240 h. A similar trend of losses in tensile strength can be seen for the blank and drug-loaded ﬁbers.
S.-F. Chou, K.A. Woodrow Journal of the mechanical behavior of biomedical materials 65 (2017) 724–733
729
0TFV 15TFV 30TFV 40TFV 
1hr 
48hrs 
240hrs 
0 10 20 30 40 50
0
20
40
60
80
Mass Loss (%)
S
hr
in
ka
ge
( %
)
0 10 20 30 40 50
0
20
40
60
80
Mass Loss (%)
S
hr
in
ka
ge
(%
)
0 10 20 30 40 50
0
20
40
60
80
Mass Loss (%)
S
hr
in
ka
ge
(%
)
0 10 20 30 40 50
0
20
40
60
80
Mass Loss (%)
S
hr
in
ka
ge
(%
)
Fig. 6. (a) Percentage shrinkage and mass loss of 20PCL/80PLGA ﬁbers with and without TFV after 1, 48, and 240 h in the release media. A linear correlation of sample shrinkage and
mass loss is observed. (b) SEM images of 20PCL/80PLGA ﬁbers with and without TFV loading after in the release media for 1, 48, and 240 h followed by mechanical testing. Scale
bar=2 μm.
0 48 96 144 192 240
0
20
40
60
80
100
Time (hr)
C
um
ul
at
iv
e
R
el
ea
se
(%
)
0 48 96 144 192 240
0
20
40
60
80
100
Time (hr)
C
um
ul
at
iv
e
R
el
ea
se
(%
)
100PCL 80L20GA 60L40GA 40L60GA 20L80GA 100PLGA
Fig. 7. Cumulative release curves of PCL/PLGA blend ﬁbers loaded with 15% TFV (a) prior to mechanical stretching (b) after mechanical stretching to failure. (Open circles) 100PCL,
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of PCL/PLGA blend ﬁbers mechanically stretched followed by a 10-day in vitro release study. Note that 100PCL ﬁbers showed surface aggregates after mechanical stretching (Fig. 4)
whereas the aggregates were not seen here after the release study. Scale bar=2 μm.
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to occur. This explains the signiﬁcant loss of mechanical properties of
the blank PCL/PLGA (20/80) ﬁbers after 240 h in the release media
(Fig. 5b and c). In general, sample shrinkage, mass loss, and surface
defects of the PCL/PLGA (20/80) ﬁbers with and without TFV are
observed and contribute to the overall decrease in measured mechan-
ical properties.
3.7. In vitro TFV release after mechanical stretching of the ﬁbers
We performed in vitro drug release studies on TFV-loaded (15 wt%)
PCL/PLGA samples at various compositions after tensile tests to show
changes in release proﬁles due to mechanical deformation. Sustained
release of TFV depended on PLGA content in PCL/PLGA ﬁbers before
mechanical stretching (Fig. 7a). By contrast, ﬁbers being stretched to
failure showed increases in release rates where PCL/PLGA (20/80)
ﬁbers reached 70% cumulative release at 96 h as compared to the same
level of cumulative percentage release at 240 h without mechanical
stretching (Fig. 7b). Changes in TFV release proﬁles are perhaps due to
decreased ﬁber diameters (Fig. 4) resulting in an increase in the surface
area of the fabrics. Furthermore, stretched ﬁbers have a smaller ﬁber
diameter that decreases the distance for core-partitioned TFV to
diﬀuse. In addition, stretched ﬁbers in the release media at 240 h were
free of surface aggregates as observed from SEM images (Fig. 7c),
suggesting that the surface aggregates (Fig. 4) may be attributed to
TFV. In addition, in vitro drug release studies indicated an above 90%
cumulative release of TFV for PCL and PCL-rich ﬁbers at 240 h
(Fig. 7b), which resulted in the disappearance of TFV surface aggre-
gates. At high PLGA concentrations, the surface morphologies and ﬁber
structure appeared to be similar to our previous observations (Fig. 6).
Surface defects due to TFV release can also be seen on the PLGA and
PLGA-rich ﬁbers. In general, mechanical stretched ﬁbers exhibit a
faster release rate.
3.8. TFV partitioning probed by mechanical testing
We developed a mechanical model to quantify TFV partitioning in
the electrospun PCL/PLGA ﬁbers to understand the correlations
between mechanical properties, TFV release rates, and drug and
polymers interactions. The average Young׳s moduli of blank PCL/
PLGA ﬁbers were within the upper and lower bound limits from rule of
mixtures (Fig. 8a). In addition, the model predicts 80% of the total TFV
is associated with PCL and 20% of the total TFV is associated with
PLGA, which is in good agreement with the experimental results from
the blend PCL/PLGA/TFV ﬁbers (Fig. 8b). To verify these results, we
individually electrospun PCL/TFV and PLGA/TFV ﬁbers with prede-
termined amounts of TFV as predicted by the model and stacked them
into a single composite mat. Results from mechanical testing of the
stacked ﬁbers (Fig. 8b), consisting 80% of the TFV in PCL ﬁbers and
20% of the TFV in PLGA ﬁbers, showed good agreement with the model
prediction. In addition, average Young׳s moduli of the stack ﬁbers
exhibited comparable values as the experimental results from PCL/
PLGA blend ﬁbers loaded with 15 wt% of TFV. In general, we report a
mechanical model to estimate TFV partitioning in PCL/PLGA electro-
spun blend ﬁbers.
4. Discussion
In this work, we correlate mechanical properties of PCL/PLGA
blend ﬁbers with TFV release. We showed that increasing PLGA
composition oﬀsets the stiﬀening attributed to incorporation of TFV
in the blend ﬁbers. Furthermore, drug release signiﬁcantly decreased
the mechanical properties of PCL/PLGA (20/80) ﬁbers. Moreover, a
mechanical model was used to infer preferential partitioning of TFV
into the PCL phase compared to the PLGA phase of blended ﬁbers,
which we further conﬁrmed experimentally with stacked composite
ﬁbers. Our ﬁndings provide insights to drug–polymer interaction, drug
loading, and drug partitioning using electrospun blend polymer ﬁbers.
In addition, our results may inform the design of tissue engineered
biomaterial scaﬀolds that have dual requirements for maintaining
mechanical properties while also delivering agents (e.g., growth
factors) that upon release leads to substrate degradation overtime.
Mechanical properties of PCL/PLGA ﬁbers suggested that PCL
ﬁbers had a lower Young׳s modulus than PLGA ﬁbers (10-fold) while
increasing PLGA content increased average Young׳s moduli of the
blend ﬁbers. Several studies report on the dependence of ﬁber diameter
on the average Young׳s modulus of PCL ﬁbers (Croisier et al., 2012;
Jordan and Korley, 2015; Tammaro et al., 2015). In addition, tensile
strength of the PCL ﬁbers appeared to be independent of ﬁber
diameter. By contrast, PLGA exhibits a wide range of mechanical
properties mainly due to its lactic to glycolic acid ratios (Li et al., 2006,
2002; Meng et al., 2010). The observed higher Young׳s modulus of
PLGA as compared to PCL is in agreement with literature. In addition,
mechanical properties of PCL/PLGA blend ﬁbers exhibited a gradual
increase in Young׳s modulus with increasing PLGA content in the ﬁbers
(Fig. 2a), which has also been observed by others (Bianco et al., 2013;
Liang et al., 2013; Torricelli et al., 2014). In a previous study, the
tensile strength of PCL/PLGA (80/20) ﬁbers were reported to be 2–
3 MPa (Franco et al., 2011). Our results are in agreement with these
reported values. In general, PLGA has a higher intrinsic mechanical
stiﬀness and strength than PCL. Increasing PLGA composition in the
blend ﬁbers results in a gradual increase in mechanical properties,
suggesting that the two polymers are miscible.
Fig. 8. Prediction of TFV partitioning using a mechanical model. (a) Rule of mixtures showing PCL/PLGA blend ﬁbers fell in between the upper bound limit (Voigt model: axial loading)
and the lower bound limit (Reuss model: transverse loading). (b) Correlations between model prediction of TFV partitioning: 80% of TFV is in PCL and 20% of TFV is in PLGA.
Experimental results on blend ﬁber loaded with TFV, and experimental results on stacked ﬁber pre-loaded with the exact amount of TFV in either PCL or PLGA ﬁbers.
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PCL/PLGA ﬁbers incorporating TFV at various loadings were
investigated to show eﬀects of drug–polymer interactions on mechan-
ical properties. Changes in average Young׳s moduli of drug-loaded
ﬁbers indicated a high amount of drug–polymer interactions (Fig. 2a).
A previous study using PLA/PEG (87/13) ﬁbers loaded with 10 wt% of
5-nitro-8-hydroxyquinoline, an antibacterial drug, showed signiﬁcant
decreases in Young׳s modulus due to drug–polymer interactions
(Toncheva et al., 2016). Others have also reported changes in
Young׳s modulus for PLGA ﬁbers loaded with small molecule drugs
(Mo et al., 2015; Ranjbar-Mohammadi et al., 2016). By contrast, an
increase in elastic modulus was reported for PCL ﬁber loaded with 5 wt
% of linezolid (Tammaro et al., 2015). Collectively, these ﬁndings
support that drug–polymer interactions aﬀect mechanical properties of
electrospun polyester ﬁbers. In addition, drug–polymer interactions
become more pronounced at higher loading as expected and was
suggested in a study using metronidazole loaded up to 40 wt% in
PCL/gelatin (50/50) ﬁbers (Xue et al., 2014). Our results showed that
increasing TFV loading (up to 40 wt%) has minimal eﬀects on elastic
modulus and tensile strength of the PCL/PLGA (20/80) ﬁbers due to
oﬀsetting drug–polymer interactions (Fig. 2c). In general, drug–
polymer interactions signiﬁcantly aﬀect mechanical properties of
electrospun blend ﬁbers while increasing drug loading may magnify
these interactions and reduce the corresponding mechanical proper-
ties.
We hypothesized that the mechanical performance of polymer
ﬁbers signiﬁcantly decreases due to their degradation in simulated
physiological conditions. For example, polyester ﬁbers such as poly(-
lactic acid) (PLA) and poly(glycolic acid) (PGA) resorbed and degraded
in vivo resulting in low mechanical properties (Majola et al., 1991;
Paganetto et al., 1991). In a previous study, biodegradable polyester-
urethane ﬁber scaﬀolds consisting of poly[3-(R-hydroxybutyrate)-co-
(ε-caprolactone)]-diol and poly[ε-caprolactone-co-glycolide]-diol
linked with 2,2,4-trimethylhexamethylene diisocyanate were mechani-
cally stretched in uniaxial tension after a predetermined time of
degradation in PBS (Limbert et al., 2016). The average Young׳s
modulus and tensile strength decreased 20% and 50% after 4 days of
degradation and an additional 20% and 40% by 24 days, respectively.
Changes in mechanical properties during degradation have been
attributed to hydrolysis of the segmented structure of PU-based
materials. Furthermore, cleavage of the ester linkages resulting in
fragmentation of the ﬁbers provides direct evidence of degradation.
Another possible degradation mechanism includes erosion of the ﬁber
surfaces. For example, PLA/PCL (90/10) ﬁbers showed a 10% loss in
mass leading to an 80% decrease in strength over 16 weeks of
investigation in PBS (Vieira et al., 2011). Our results for blank PCL/
PLGA (20/80) ﬁbers showed a 10% mass loss with a decrease of 80% in
strength after 10 days in PBS. Although the loss of strength in our study
is comparable with previous results, our data suggest a faster degrada-
tion rate. The diﬀerences are perhaps due to a higher hydrolytic
damage on PLGA than PLA. Overall, polymer degradation plays an
important role in the decrease of mechanical properties.
Fiber mechanical properties are also signiﬁcantly aﬀected by drug
release. Our results suggests that TFV release resulted in signiﬁcant
loss of mechanical properties at early time points (e.g., 1 h and 48 h).
By contrast, at later time points (240 h) when cumulative TFV release
reached above 80%, loss of mechanical properties in drug-loaded ﬁbers
were comparable to the blank ﬁbers. These results suggest that ﬁber
degradation dominated the mechanical attributes at these later times.
Furthermore, the decrease in mechanical properties appeared to be
faster in ﬁbers with a higher drug loading (e.g., 30 wt% and 40 wt%),
indicating a loss of mechanical property related to release. We also
measured TFV release from PCL/PLGA ﬁbers after being mechanically
stretched. Our results show that stretched ﬁbers release drug faster
than the non-stretched ﬁbers. From a design perspective for drug-
eluting ﬁbers, changes in release rate due to mechanical disturbance
may promote an undesired daily dosage. Therefore, future work may be
necessary to decouple the dependence between drug release and
mechanical properties.
In blend polymer ﬁbers, drug partitioning was often observed in
conjunction with tunable release rates, such as in the case of poly(ε-
caprolactone) and poly(oxyethylene- b-oxypropylene-b-oxyethylene)
blend ﬁbers (Natu et al., 2010). Similarly, burst of lysozyme was
suggested from partitioning in water soluble poly(ethylene oxide)
(PEO) blended with polyester-based polymers ﬁbers (Kim et al.,
2007). However, quantiﬁcation of drug partitioning is deemed to be
very diﬃcult using release kinetics alone since many factors (e.g.,
surface drug, wetting, erosion, diﬀusion, etc.) are interrelated. In this
study, we established a mechanical model and used it to predict drug
partitioning in blended PCL/PLGA 80/20 ﬁbers. Our mechanical
model was based on the elastic modulus in composite theory with
additional terms (i.e., individual increase or decrease in modulus after
drug incorporation) for the Voigt model. We validated TFV partitioning
predicted from our model by using pure PCL or PLGA ﬁbers individu-
ally loaded with predetermined drug content and stacked them into a
composite. The mechanical properties of the stacked materials were
similar to the blend ﬁbers. To our knowledge, this is the ﬁrst report
quantifying drug partition in blend electrospun nanoﬁbers using
mechanical testing. Our model provides an easy and straightforward
method to predict drug partitioning in electrospun polymer blend
ﬁbers. Overall, drug partitioning has signiﬁcant impact on release
proﬁles and mechanical properties of electrospun blend polyester
ﬁbers. The current mechanical model may provide a rapid and direct
method to examine drug partitioning.
5. Conclusions
In summary, we report correlations between mechanical properties
and drug release rates of electrospun blend ﬁbers. Our results showed
that incorporating TFV into PCL/PLGA ﬁbers signiﬁcantly modiﬁed the
mechanical properties from blank ﬁbers, suggesting a high level of
drug-polymer interactions. TFV release decreased mechanical proper-
ties signiﬁcantly at early time points. Pre-stretched PCL/PLGA blend
ﬁbers to failure showed higher release rates as compared to the non-
stretched samples. Drug partitioning in PCL/PLGA ﬁbers was evalu-
ated using a mechanical model, and experimental data using stack ﬁber
conﬁgurations conﬁrmed that 80% of the TFV is in the PCL phase and
20% of TFV is in the PLGA phase. Our study contributes to scientiﬁc
understanding of mechanical performance of drug-eluting ﬁbers.
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